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Background: The direct cost of excessive alcohol consumption to health services is substantial but dwarfed by the
cost borne by the workplace as a result of lost productivity. The workplace is also a promising setting for health
interventions. The Preventing Alcohol Harm in Liverpool and Knowsley (PrevAIL) project aimed to evaluate a
mechanism for detecting the prevalence of alcohol related liver disease using fibrosis biomarkers. Secondary aims
were to identify the additive effect of obesity as a risk factor for early liver disease; to assess other impacts of
alcohol on work, using a cross-sectional survey.
Methods: Participants (aged 36-55y) from 13 workplaces participated (March 2011–April 2012). BMI, waist circumference,
blood pressure and self-reported alcohol consumption in the previous week was recorded. Those consuming more
than the accepted UK threshold (men: >21 units; female: >14 units alcohol) provided a 20 ml venous blood sample
for a biomarker test (Southampton Traffic Light Test) and completed an alcohol questionnaire (incorporating the
Severity of Alcohol Dependence Questionnaire).
Results: The screening mechanism enrolled 363 individuals (52 % women), 39 % of whom drank above the
threshold and participated in the liver screen (n = 141, complete data = 124 persons). Workplaces with successful
participation were those where employers actively promoted, encouraged and facilitated attendance. Biomarkers
detected that 30 % had liver disease (25 %, intermediate; 5 % probable). Liver disease was associated with the
frequency of visits to the family physician (P = 0.036) and obesity (P = 0.052).
Conclusions: The workplace is an important setting for addressing alcohol harm, but there are barriers to
voluntary screening that need to be addressed. Early detection and support of cases in the community could avert
deaths and save health and social costs. Alcohol and obesity should be addressed simultaneously, because of their
known multiplicative effect on liver disease risk, and because employers preferred a general health intervention to
one that focused solely on alcohol consumption.
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Globally, 5.9 % of all deaths are attributed to the con-
sumption of alcohol [1]. Alcohol-related liver disease is a
major contributor to these deaths [2], and accounts for
around half of all alcohol-attributed mortality in England
[3]. While Europe as a whole saw falling rates of deaths* Correspondence: p.a.cook@salford.ac.uk
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Finland experienced a five-fold increase over the same
time period, linked to increased consumption of alcohol
[4]. Alcohol-related liver disease disproportionately affects
the working age population, and affected individuals are
now younger on average than in previous decades: the
most common age category for hospital admission for al-
coholic liver disease in England dropped from 55–64 years
to 45–54 years (from 1989/90 to 2002/03) [5]. The profile
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should be concerned about this escalating alcohol harm,
because the workplace bears the brunt of the costs. In the
USA, excessive alcohol consumption cost the economy an
estimated $223.5 billion in 2006, of which 72 % was from
lost productivity (including premature mortality and ab-
senteeism) [7]; in the UK, the total costs of alcohol harm
were estimated to be £21billion in 2010 [8], of which 35 %
was from lost productivity. In contrast, the direct cost to
health services in both countries was lower, at 11 % in the
USA [7] and 17 % in the UK [8]. Such economic costs are
thought to considerably underestimate the impacts on the
workplace, since alcohol is also responsible for work ab-
senteeism and underperformance, although quantifica-
tion of this is difficult. An Australian study found that,
amongst employees who consumed alcohol, 3.5 % ac-
knowledged at least one alcohol-related sick day in the
previous three months [9]. A longitudinal study in the
UK showed that those who consumed more than the
recommended ‘safe’ level at baseline (21 units/168 g
of alcohol for men; 14 units/112 g for women in a
week) had twice as many days off sick during follow-up
[10]. At a population level, a 10 % increase in alcohol
consumption in Norway was associated with a 6.2 % in-
crease in absenteeism [11]. In addition, productivity de-
creases if drinking before work (1.8 % of workers reported
this in a national US survey) or during the workday (7.1 %,
as previously), as well as working under the influence of
alcohol (1.7 %) or with a hangover (9.2 %) [12]. The major-
ity of absences are likely to occur in those drinking at risky
levels, however, such persons are not necessarily identifiable
as being alcohol dependent (for example, classed as occa-
sional binge drinkers [9] or ‘moderately risky’ drinkers [10]).
Obesity also causes liver disease [13], as well as being
a possible consequence of over consumption of alcohol
because of its calorific content and effects on appetite
[14]. Further, obesity may be inadvertently promoted by
the working environment, through sedentary behaviour
[15]. Large UK cohort studies show that obesity in combin-
ation with alcohol use leads to a particularly high risk of
liver disease [13, 16], in a ‘supra-additive’ effect. Although
damage to the liver is reversible by lifestyle changes if de-
tected early [17], such detection has historically been diffi-
cult. Newer diagnostic tests now make early detection
possible, but they are rarely used in community or primary
care settings. Previous studies have shown alcohol brief in-
terventions (BI—which typically consist of simple advice),
to be moderately successful in workplaces [18, 19]. Simple
workplace screening using a liver function test and Alcohol
Use Disorder Identification Test—AUDIT—was sufficient
to elicit a reduction in drinking that remained apparent
12 months later [20].
No previous study has investigated the effect of using
newer diagnostic tests for liver disease in the workplace.The Preventing Alcohol Harm in Liverpool and Knowsley
(PrevAIL) project aimed to evaluate a mechanism for de-
tecting the prevalence of alcohol related liver disease
amongst risky drinkers using fibrosis biomarkers. Second-
ary objectives were to: detect the prevalence of early stage
liver disease using a non-invasive biomarker test to detect
fibrosis; determine the interaction of alcohol with obesity as
co-risk factors for liver disease; and assess other impacts of
alcohol intake on participants’ work and social interactions.
Methods
Subjects and setting
The areas of Liverpool and Knowsley in north west
England experience particularly high levels alcohol-
specific mortality (Liverpool, men: 29.12 per 100,000,
women 13.19; Knowsley, men: 16.59; women: 11.79) com-
pared to England as a whole (males: 14.6; females: 6.8)
[21] and were thus selected for study. Two thirds (67 %)
of persons in the study area were recorded to be in em-
ployment [22]. The sampling frame for screening was
adults aged 36–55 years. The peak for diagnosing alcohol
related liver disease is 45–54 years [5], as such, to screen
for those most at risk we used 55 years as the upper cut-
off. The study was part of a bigger study (not reported
here) that also recruited via general practice and commu-
nity events [23].
Sample size calculations
The prevalence of liver damage among employees drink-
ing above the recommended levels was unknown since
we could find no similar studies carried out in the com-
munity. However, a prevalence study in France using
biomarkers found 3 % presumed fibrosis in all persons
regardless of alcohol consumption status [24]. We as-
sumed that up to 10 % of all those drinking at risky levels
could show signs of damage, as had previously been as-
sumed for a primary care population screening study, the
Alcohol and Liver Disease Detection Study (ALDDeS),
which subsequently found a prevalence of 11 % [25]. Thus,
we estimated a sample size of 100 would be sufficient to
estimate prevalence with a 6 % margin of error and a 95 %
confidence interval. Since around a third of the population
in this region drink at ‘increasing risk’ (or higher) levels
(28 %) [26], we estimated that 300 individuals were re-
quired for the initial alcohol consumption screen.
Recruitment
Between March 2011 and April 2012, screening loca-
tions were selected following sensitisation briefings with
local employers. Medium to large workplaces (employ-
ing >400 persons) were first identified through business
networks, health promotion agencies and the Chamber
of Commerce. A range of employers were then targeted
including white collar professionals, manufacturing, public
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The project was marketed to employees as a free health as-
sessment and was promoted through posters, flyers, emails
and internal newsletters. Drop-in clinics or pre-arranged
appointments were supplied to suit each workplace, and
times/days outside the normal working day were offered to
accommodate shift workers. Assessments were conducted
in private rooms by a researcher (for questionnaires) and a
nurse (for clinical screen).
In total, 37 organisations were approached: 13 agreed
to take part, ten declined and we were unable to make
meaningful contact with the remaining 14. Of the 13,
not all were willing/able to tell us how many employees
met the age criteria; of the seven who did, screening
participation was 1.8–5.5 % in four large organisations
(employing >200 eligible persons) and 18–25 % in three
small organisations (<200 employees).
Screening procedure
Alcohol consumption screen
Volunteers reaching the inclusion criteria were first
screened using a short structured screening form to as-
sess alcohol consumption in the week prior to the survey
(for each type of alcohol, the quantity and frequency
consumed), demographic information (gender, ethnicity,
age and postcode—to enable allocation of an area-level
measure of deprivation), and conditions that affect liver
function (Hepatitis B or C, liver disease /cirrhosis and
diabetes). Those drinking more than the accepted UK
threshold for ‘lower risk’ drinking in the previous week
(21 units for men, 14 for women, 1 unit = 8 g pure
alcohol) [27] were invited to a liver screen.
Clinical and liver screen
Height, weight, waist circumference and blood pressure
were taken and recorded on case report forms. A 20 ml
venous blood sample was drawn into vials appropriate
for a conducting a range of standard biochemical and
haematological analyses. Blood samples were transported
at ambient temperature to the Department of Pathology
at Alder Hey Children’s Foundation Trust (Liverpool),
processed and analysed within 6 h of venepuncture. Re-
sidual serum samples were stored at −80 °C for up to
3 months.
The non-invasive test of liver fibrosis used was the
Southampton Traffic Light (STL) test developed by Sheron
et al. [17, 25]; this simple algorithm is designed for ease of
use and interpretation in primary care. The STL test com-
prises two serum biomarkers of fibrosis: hyaluronic acid
(HA) and procollagen type III N-terminal peptide (PIIINP),
together with the platelet count [17]. HA was measured
in frozen serum using an ELISA kit supplied by Elitech
(formerly Corgenix) and a platelet numbers were deter-
mined as part of a full blood count. Frozen serumsamples were sent to the Department of Pathology at
Southampton University Hospital Trust for analysis of
PIIINP by a radioimmunoassay method using kits sup-
plied by Orion. Using the STL system, the risk of fibrosis
in participants was categorised according to the following
criteria: HA >30 ng/ml or a PIIINP >5.5 μg/ml = score +1;
HA >75 ng/ml = score +2; platelet count <150 × 109/l =
score +1 [17]. Those scoring zero were categorised as
low risk for liver fibrosis and cirrhosis (green), those
scoring +1 were intermediate risk (amber—‘some degree
of liver fibrosis possible’) and those scoring of ≥2 were
high risk (red—‘liver fibrosis probable, with severe liver
fibrosis or cirrhosis a possibility’) [25].
Blood pressure was measured with a manual sphygmo-
manometer, and categorised as high (systolic ≥ 140 mmHg
and/or diastolic ≥ 90 mmHg) or normal/low. Weight was
taken with light clothing and shoes removed. Height was
measured using a portable stadiometer (Leicester Height
Measure, Seca). The heights and weights of participants
were used to calculate BMI (kg/m2). Waist circumferences
were also recorded. Because of the limitations of using
BMI or waist circumference independently as measures of
obesity (for example, BMI does not account for highly
muscular adults), the two were used in combination to
categorise risk of health complications relating to obesity,
using the categories ‘no increased risk’, ‘increased risk’ and
‘high / very high risk’ of obesity-related problems [28, 29].
Alcohol behaviours and social impact survey
Participants were given a detailed questionnaire including
a measure of alcohol dependency (Severity for Alcohol
Dependence Questionnaire: SADQ) [30]. Mild/moderate
dependency was defined as a score of 4 or more on SADQ
(no participants were severely dependent). Alcohol-related
experiences in the last month were assessed by the ques-
tion ‘have you experienced any of the following after
drinking…’ followed by 34 items, including: sleeping bet-
ter; feeling confident; injuring themselves or others; visit-
ing a general practitioner or a nurse; driving a car. Items
relevant for employees and workplaces were analysed for
this paper (missed work/class/lectures after drinking; gone
to work/class/lectures; present with a hangover, or being
late after drinking; avoided clients/customers; avoided a
boss/teacher/tutor). The items were worded as ‘work/
class/lectures’ to ensure relevance for students as well as
working adults in the wider PrevAIL study. Since the indi-
viduals recruited for this study were all in the workplace,
we have interpreted this item to predominantly reflect
performance at work.
Ethics
The predominant ethical issues were the sensitivity of
the topic of alcohol use in the workplace and the ar-
rangements for feedback to participants. At each point,
Table 1 Demographic details of individuals screened for


















5 (most deprived) 99 27.3
Missing 30 8.3
Drinking classificationa
Non drinker 13 3.6
Lower risk or none in last week 209 57.6
Increasing risk 114 31.4
Higher risk 27 7.4
aFor men, lower risk: <22 units in previous week; increasing risk: 22–50 units;
higher risk: >50 units. For women: lower risk: <15 units; increasing risk: 15–35
units; higher risk: >35 units
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mation, given the opportunity to ask questions and in-
formed of their right to withdraw. Confidentiality was
stressed throughout. A trained nurse gave participants
feedback on their alcohol consumption, body mass index
(BMI), waist circumference and blood pressure verbally
and in writing (on a feedback sheet). Alcohol leaflets
that included information on units in different drink
types and risks at different levels of drinking were of-
fered to all participants, and those drinking over the rec-
ommended limits were advised of this in writing and
verbally immediately after the assessment. The leaflets
had been developed by Liverpool NHS Primary Care
Trust for use in health services locally. Those participat-
ing in the liver screen were provided with individual
feedback of their blood test results (sent to them by
post). Participants’ family physicians were notified of re-
sults of blood tests if the participant had given consent for
us to do so. Ethics and research governance approvals
were gained from Liverpool John Moores University Eth-
ics Committee, Liverpool PCT, and NHS Ethics (reference
number: 10/H1013/65).
Statistical analysis
Lab and clinical data were merged with alcohol behaviour
and impact data using participant identifiers. Data were
analysed using SPSS v.17. Where data were available (n =
333), individual postcodes were assigned to deprivation
quintiles based on Index of Multiple Deprivation (IMD)
2010 Scores. Red (probable fibrosis) and amber (possible
fibrosis) STL outcomes were categorised as positive. Pear-
son χ2 was used to explore relationships between STL out-
come, demographics and risk factors. Demographics and
risk factors were combined into a single logistic regression
model to find predictors of a positive STL.
Results
Recruitment
A total of 363 individuals from 13 workplaces were re-
cruited to the study, just over half of whom were women
and most were white British (97 %; Table 1). According
to their previous week’s consumption, 27 (7.4 % of the
sample) were higher risk drinkers and 114 were increas-
ing risk drinkers (31.4 %), and these individuals were in-
vited to take part in the liver screen.
In total, 141 people were invited and 124 took part. Only
one person chose not to participate, with the remaining 16
unable to provide a sufficient sample and are excluded
from further analysis. Of the 124 screened individuals,
62.3 % were male. Overall, 35.6 % lived in the two most
deprived quintiles in England. Those who were eligible
but were unable/unwilling to provide a blood sample had
drunk less alcohol in the previous week (median 23 units
vs 31 units: P = 0.044) and were younger (77 % were aged36–45 years and 23 % 46–55 years, whereas 49 % of the
final screened group was 36–45y: P = 0.035).Findings from the liver screen
The STL test defined seven (5.6 %, 95 % CI 1.48–9.71 %)
participants as high risk of liver disease (red: probable
fibrosis). All were ‘increasing risk’ drinkers. STL also de-
fined 30 (24.2 %, 16.7–31.7 %) further participants as
intermediate risk for liver disease (amber: possible fibro-
sis), with the remainder (87, 70.2 %) at low risk. Being
STL positive (red or amber) was significantly associated
the frequency of general practice (family physician) visits
(P = 0.036) (Table 2), while there was a tendency for
obesity (P = 0.052) and deprivation (P = 0.077) to increase
the risk of liver disease. In logistic regression, demograph-
ics, drinking history and metabolic indicators (obesity and
blood pressure) were not statistically significant predic-
tors of STL positivity (i.e. liver disease). There was a ~3-
fold higher odds of a positive STL result among persons
who were mildly or moderately dependent on alcohol
Table 2 Factors associated with a positive liver disease screen using the Southampton Traffic Light classification system (n = 124)
Characteristic Univariate analysisa Logistic regression
n % P AOR 95 % CI P
Gender 0.181 0.276
Male 76 34.2 1.71 0.65–4.47
Female 48 22.9 Reference category
Age 0.637 0.857
36–45 61 27.9 Reference category
46–55 63 31.7 1.08 0.46–2.56
Deprivation quintile 0.077 0.141
Quintiles 1 & 2 (most affluent) 47 27.7 Reference category
Quintile 3 31 41.9 1.75 0.62–4.94
Quintile 4 19 5.3 0.83 0.01–0.83
Quintile 5 (most deprived) 24 37.5 1.09 0.32–3.67
Missing 3 33.3 1.61 0.12–22.33
Frequency of family physician/ nurse visits in last year 0.036 Not included in model.
Never 22 18.2
Less than monthly 89 28.1
At least monthly 12 58.3
Missing 1 100.0
Dependence on Alcoholb 0.280 0.069
No dependence 98 27.6 Reference category
Mild or moderate dependence 26 38.5 2.85 0.92–8.84
Drinking classificationc 0.475 Not included in model.
Increasing risk 99 31.3
Higher risk 25 24.0
Obesity risk classification 0.052 0.094
No increased risk 61 19.7 Reference category
Increased risk 28 39.3 2.54 0.86–7.46
High risk or very high risk 35 40.0 2.84 0.99–8.17
Blood pressure 0.385 0.939
Low or normal blood pressure 84 29.8 Reference category
High blood pressure 36 33.3 0.83 0.30–2.29
Missing 4 0.0 0.00 0.00–0.00
Total 124 29.6
AOR Adjusted odds ratios
aPearson χ2 bSADQ score 4–34. cFor men, lower risk: <22 units in previous week; increasing risk: 22–50 units; higher risk: >50 units. For women: lower risk: <15 units;
increasing risk: 15–35 units; higher risk: >35 units
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0.92–8.84), although this was not significant (P = 0.069).
Other potential work-related harms
Of those who completed the liver screen (n = 124), one
had missed work after drinking in the last month; and
32 (26 %) had gone to work in the last month but reported
their performance was ‘under par’ e.g. being present with a
hangover, being present after drinking, or being late afterdrinking or they had avoided clients/customers or boss
after drinking. There was no association between drinking
classification (increasing risk, higher risk) and self-reported
likelihood of going to work but performing under par due
to alcohol (χ2 = 0.627, P = 0.428). The most common type
of under-par performance was self-reported attendance at
with a hangover (n = 27). Again, there was no association
between drinking classification and likelihood of going to
work with a hangover (χ2 = 0.091, P = 0.763).
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Feasibility of screening in workplaces
In total, 363 persons from 13 workplaces took part in
the study, and 39 % of these were identified as having
consumed more than the accepted UK upper limits of
alcohol in the previous week. Around 30 % of these
people who drank at risky levels were found to be at in-
creased risk of clinically significant liver disease. More-
over, the individuals detected in this study to have early/
moderate liver disease also were heavier users of the
NHS (i.e. had more self-reported visits to the family
physician) despite (at that point) being asymptomatic for
their liver disease. These findings, derived from a variety
of workplace types (ranging from office-based workers
to factory employees), suggest a substantial impact of al-
cohol on the workplace. Whilst liver function blood tests
have been conducted in workplaces in Sweden as part of
a brief intervention [20], PrevAIL is the first study that
we know of to incorporate the use of more accurate fi-
brosis biomarkers in the workplace.
Despite some challenges in accessing workplaces, of
those attending the free health assessment, participation
in the full liver screen amongst employees identified as
drinking at risky levels was very high, at 99 %. Thus, for
this step, response rates were higher than for those
achieved in other community settings [23, 25]. The wider
PrevAIL study also recruited individuals via a postal sur-
vey administered by primary care physicians (family doc-
tors). The results are not presented here, but participation
was very low (8.4 %, of whom only 18 % responded to our
invitation to the clinical examination, bringing the overall
response rate to approximately 1.4 %) [23], suggesting that
workplaces were a more efficient way of engaging with the
target population. Workplaces that showed successful
participation were characterised by active encourage-
ment to take part and flexibility by employers with
working arrangements. However, there were challenges
to implementing screening. Of 37 workplaces contacted,
only thirteen took part. Employers declined for a range
of reasons: employees not being able to leave their
desks; uncertain economic climate (e.g. going into ad-
ministration); co-occurrence of similar health-related
projects; and perceptions of alcohol as being too sensitive.
Some organisations predominantly employed people under
the age of 35 years (the lower bound for PrevAIL).
Screening participation was relatively low in the large
organisations (employing >200 eligible persons), ranging
from 1.8–5.5 %, while three smaller organisations (<200
employees) recruited at a higher rate of 18–25 %. This was
lower on average than a Swedish study (~15 % of ~6000
staff were recruited), which also collected blood samples
in workplaces as part of a brief intervention [20]. Partici-
pation rates for an online alcohol intervention in the
workplace have also been found to be low and variablebetween organisations, ranging from 2 % and 12 % in local
authorities, to as high as 35 % in a petro-chemical com-
pany [31].
Despite our best efforts to emphasise confidentiality,
anecdotally we heard that some employees had avoided
participation due to fear of disclosure. We did not ascer-
tain whether workplaces had alcohol policies in place,
such as a zero alcohol in the workplace policy. If this
was the case, some employees would be reluctant to
undertake screening. This would need to be considered
in new studies exploring the feasibility of such initiatives.
Among those who took part in an online alcohol inter-
vention in England [31], 40 % were not confident about
the confidentiality. It is difficult to assess this lack of confi-
dence among those who do not take part, and further
qualitative research should be carried out to understand
this and other potential barriers. For some participants,
the opportunity to have a liver screen without the involve-
ment their own doctor was attractive, and 13.5 % (n = 21)
of our participants chose not to provide their family doc-
tor’s contact details.
Prevalence of liver disease amongst risky drinkers
In total, 124 people identified as risky drinkers donated
a full blood sample for this study. Of these, over 1 in 20
were classed within the ‘red’ category and 1 in 4 were
‘amber’. Previous research in a clinic population demon-
strated that STL positive (red and amber) individuals
have a significantly increased mortality risk: of 641 pa-
tients with suspected liver disease followed for an average
of 3.4 years, 16 % of red and 3.4 % of amber patients died
from liver disease, while there were no deaths among indi-
viduals categorised as green (low risk) [17].
Previous studies have been mostly carried out in clin-
ical settings [17], providing measures of prevalence of
populations seeking care, and limiting the understanding
of risk within the community. The ALDDeS study used
the STL algorithm on a community sample of 10,000 in-
dividuals recruited through general practice, and found
11 % red and 40 % amber [25]. ALDDeS used a higher risk
population comprising those screening positive on AUDIT
(versus PrevAIL’s drinks diary). A study of individuals re-
cruited through a community screening programme in
France (using an alternative biomarker combination, known
as FibroTest) found a prevalence of 1.5 % for confirmed
fibrosis and up to 3 % for presumed fibrosis in all persons
regardless of drinking status [24]. Thus our prevalence esti-
mates fall within those for the higher risk ALDDeS popula-
tion and the lower risk French population.
Predictors of presumed fibrosis
The literature demonstrates a supra-additive effect of
alcohol and obesity on the probability of liver damage
[13]. Our relatively small sample size was not sufficient
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association STL positivity and obesity. Nevertheless, strat-
egies are required that act jointly to reduce alcohol
consumption and obesity as this would provide greater
potential to reduce liver disease than tackling each issue
separately. Further, because of the calorific content of al-
cohol and the associations between drinking alcohol and
consuming food [14], reducing alcohol consumption can
aide weight reduction. Employers should be motivated to
tackle both issues together, since both alcohol and obesity
lead to lost productivity [7, 32, 33].
Impact of alcohol on the workplace
Alongside a high burden of hidden liver disease, we re-
corded significant impacts of alcohol on the workplace:
we estimate that 9 % of the workforce had performance
that was affected by alcohol in the previous month (ex-
trapolated from the 39 % of who were drinking at risky
levels and filled out the experiences questionnaire). Al-
though alcohol is widely understood to be very costly in
terms of productivity, this is mainly estimated from sick-
ness absence data [7, 33]. The true cost of alcohol to the
economy is hard to measure but should include being
present at work but with reduced performance.
Potential strategies for improving engagement with
workplaces
We found that workplaces were more likely to engage
with the screening if we offered a more holistic health
check (since alcohol was deemed too sensitive to be the
sole focus). Future interventions could have a more ex-
plicit aim to tackle multiple health issues of relevance to
the workplace. Interventions that simultaneously address
obesity and alcohol, or that focus on improving safety and
productivity as well as worker health/wellbeing could be
considered. The fact that the frequency of physician/nurse
visits was associated with a positive screen should be
emphasised to employers as evidence of the impact of alco-
hol on workplace productivity and worker wellbeing. Gain-
ing access to organisations is time consuming, so once this
has been achieved it would be more efficient to roll the
intervention out as an annual event.
Limitations
In terms of assessing the prevalence of liver disease
amongst the working population, the two main limita-
tions were firstly: the relatively small sample size, leading
to insufficient power to detect statistically significant as-
sociations of liver disease with demographic variables;
and secondly: the representativeness of the screened
group given that many workplaces could not or were
not willing to take part, and amongst those that
did, participation was around 5 %. Nevertheless, theparticipation was more successful than recruitment by
mail via family physicians.
PrevAIL used a drinks diary to screen for risky drink-
ing (based on the quantity consumed in the previous
week). Inclusion in the study was influenced by unusually
heavy (or light) drinking. An alternative approach would
have been to use a brief screening tool such as AUDIT-C,
which asks about typical drinking behaviour. We ruled
this out because we hypothesised that our target popula-
tion would be habitual drinkers who drink more than the
accepted UK thresholds, but not necessarily sufficiently to
score positive on a brief tool such as AUDIT-C. The con-
sumption diary approach also gives useful information on
consumption patterns. With a larger sample, this could be
used to elucidate the relationship between total quantity,
pattern of drinking, and risk of liver disease.
As with any screening test, when moving from the higher
risk secondary care setting to the general population, the
prevalence of the targeted health condition is likely to be
markedly lower, and this affects the positive predictive
value of the test. Sheron et al. [17] modelled the STL under
a range of prevalence assumptions. The PPV of a ‘red’ grad-
ing could be as low as 30 % in a low prevalence community
sample (if the true prevalence was as low as 8 % fibrosis),
and 12 % for an amber grade. However, the negative pre-
dictive value of a green grading was high (98 %). Usually, a
low PPV for a screening test would pose an ethical issue of
unnecessary treatment for a condition or unnecessary
worry about a condition. For risky drinkers, the treatment
(here, a lifestyle intervention to reduce drinking) remains
necessary given the range of harms attributed to alcohol
and the potential for future liver damage.
We originally intended to measure fasting blood glucose,
triglycerides and cholesterol in order to detect metabolic
syndrome, and thus account for the known relationship be-
tween metabolic syndrome and non-alcoholic fatty liver
disease [34], and the synergistic relationship between diet-
ary risk and alcohol as risk factors for liver disease [13].
However, collecting a fasting blood sample proved difficult
in the workplace, and only seven blood samples were fast-
ing (5.7 % of blood samples collected where fasting status
was recorded). This occurred for a variety of reasons:
choosing to take part opportunistically on the day of the
study and not being prepared for fasting; the timing of
availability / appointment (e.g. in the afternoon) made fast-
ing too difficult; and some employers did not wish em-
ployees to be working while hungry. Thus, while we were
able to provide a risk score for liver disease, we could not
rule out non-alcoholic fatty liver disease as a cause.
Conclusions
A significant hidden burden of alcohol harm was revealed
in a sample of workplaces, making the workplace an im-
portant setting to addressing alcohol harm. However, more
Cook et al. BMC Public Health  (2015) 15:532 Page 8 of 9work is required to develop methods to encourage uptake
of voluntary screening, including bringing together mul-
tiple health issues (e.g. obesity, smoking and alcohol) to: re-
duce the burden on the workplace of hosting multiple
events; reduce participation fatigue by employees and in-
terventions; and reduce the focus on alcohol, which was
perceived as a highly sensitive issue. Such programmes re-
quire sustained relationships to be built with employers to
decrease the time and costs of approaching workplaces for
each new intervention.
To our knowledge, this is the first study to use non-
invasive biomarkers to detect liver disease in the work
place, and our estimates of liver disease prevalence en-
dorse those found by community surveys in other set-
tings. These individuals with probable liver disease were
asymptomatic in terms of liver disease but were already
utilising more primary health care resource for general
health care. A lifestyle intervention that addresses alco-
hol use would be sufficient in many cases to prevent fur-
ther development of disease. Early detection and support
for these cases could avert deaths and save considerable
health and social costs.
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